blindness and glp 1 Two new studies were just published in the Annals of Internal Medicine- (I will cover those also) glp 1 drugs and vision

Ideal Candidates for Medvi Adults with a BMI of 30+ seeking physician-supervised weight loss support Adults with a BMI of 2729.9 with at least one weight-related health condition (pre-diabetes, hypertension, high cholesterol, sleep apnea) Individuals who have not achieved sustained results through diet and exercise programs alone People seeking a medically supervised weight loss framework not just a supplement Those who want access to GLP-1 medications at a lower cost than brand-name alternatives Patients who value clinical oversight, the Medvi refill intake form process, and telehealth appointment access Individuals committed to the Medvi 3-month plan structure and willing to engage with the Medvi patient portal consistently Patients who may have insurance coverage that could offset Medvi medicine costs Who Should Avoid Medvi

[4] A telehealth encounter can accomplish the full intake, review lab results, and transmit an electronic prescription to a specialty pharmacy in one 20-30 minute visit

Others are extremely potent and stick around for days

6 CleggD